Aug 12, 2020
LASEROPTEK Co. Ltd., Announces U.S. Launch of PALLAS, First-of-its-Kind Solid State UVB Medical Dermatology Laser
Jun 15, 2020
Dompé Presents Phase II Clinical Trial Results for Ladarixin in New-Onset Type 1 Diabetes at the American Diabetes Association's Scientific Sessions
Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
Jun 12, 2020
One in Three People with Diabetes Do Not Receive Support Needed to Deal with Emotional Aspects of Living with Diabetes
Jun 11, 2020
Sun Pharma Plans to Present Clinical Insights from 25 Data Abstracts Across its Dermatology Portfolio at the 2020 AAD Virtual Meeting Experience
Jun 11, 2020
Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
Jun 06, 2020
AbbVie Presents Data Showing RINVOQ(TM) (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients
Jun 04, 2020
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
Jun 03, 2020
New First-in-Class Phase 3 TREMFYA® (guselkumab) Data Demonstrate Improvement in Psoriatic Arthritis Joint and Skin Symptoms at Week 52
Jun 03, 2020
EULAR 2020: Lilly's Taltz® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis
Jun 01, 2020
Despite Increased Competition from the Recent Launch of Janssen's Stelara, Takeda's Entyvio Continues to Shine as a Leading Ulcerative Colitis Treatment
Jun 01, 2020
Lilly's Taltz® (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
May 26, 2020
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
May 23, 2020
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks
May 18, 2020
Sight Sciences Announces Positive Clinical Results from Randomized, Controlled Trial of TearCare for the Treatment of Dry Eye Disease
May 15, 2020
Can-Fite Announces Pre-IND Submission to U.S. FDA for Piclidenoson in the Treatment of COVID-19 Infected Patients with Moderate-to-Severe Symptoms
May 13, 2020
Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027
May 12, 2020
Ulcerative Colitis Market Report 2020: Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares through 2016-2024
May 07, 2020
Novel Real-World Data Findings From Ongoing TARGET-IBD Study Published In DDW Proceedings
May 07, 2020
Global Corticosteroids Therapy Industry & COVID-19, Forecast to 2030